Journal of Multiple Sclerosis and Neuroimmunology

Search

Page Path

HOME
Search

Case Report

Favorable Response to Corticosteroid Treatment in Chronic Inflammatory Axonal Polyneuropathy: Jiwon Yang; J Mult Scler Neuroimmunol. 2022;13(1):12-15. Published online June 1, 2022; PDF

Case Report

Cost Effectiveness of First-Line Rituximab in Koreans with Neuromyelitis Optica Spectrum Disorder: Jae-Won Hyun, Hyunmin Jang, Jeongmi Park, Min Young Lee, Su-Hyun Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2020;11(2):53-58. Published online December 1, 2020; PDF

Original Article

Healthcare Costs of Multiple Sclerosis in Korea According to the Level of Disability: Jae-Won Hyun, Jae-Won Hyun, AeRan Joung, AeRan Joung, In Hye Jeong, In Hye Jeong, Su-Hyun Kim, Su-Hyun Kim, Ho Jin Kim, Ho Jin Kim; J Mult Scler Neuroimmunol. 2015;6(1):9-13. Published online March 1, 2015

Volume 15, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

6,015	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
2,666	Rituximab Treatment for Neuroimmunologic Disorders
2,372	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2,334	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
2,216	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review

Cited By
2

Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: icandr@cau.ac.kr

Copyright © 2024 by Korean Society of Neuroimmunology.